A world-first international study led by the University of South Australia has identified a new drug to stop athletes developing dementia after sustaining repeated head injuries in their career.
A neurologic pathway by which non-damaging but high frequency brain impact blunts normal brain function and causes long-term problems with learning and memory has been identified. The finding suggests that tailored drug therapy can be designed and developed to reactivate and normalize cognitive function, say neuroscientists at Georgetown University Medical Center.
ASU sociologist finds team-oriented exercises benefit us socially and can also increase life span
New brain scans and blood tests move researchers towards more sensitive diagnosis of battlefield brain trauma and evaluation of new drugs
A team of researchers, led by Philip V. Bayly in the McKelvey School of Engineering at Washington University, plans to use MRI to study the brains of healthy, uninjured individuals to create models of brain motion to enable the researchers to predict the chronic effects of repeated head impacts in both men and women.